4th Quarter - Report

KOUNTOUPES DENHAM CARR & REID, LLC for CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the pharmaceutical supply chain including proposals that would address drug shortages and national stockpile issues, including H.R.2870, the Essential Medicines Strategic Stockpile Act of 2021. Issues related to the implementation of H.R. 1319, the American Rescue Plan. Issues related to pharmacy provider status. Issues related to H.R. 5067, Preserving Access to Home Infusion Act. Issues related to H.R. 5376, the Build Back Better Act.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LORI DENHAM —
CLAYTON PATRICK HAYES —

Contacted: Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2870 (117th), H.R. 1319 (117th), H.R. 5067 (117th), H.R. 5376 (117th)

Pharmacy PHA

Issues related to proposals that would address drug shortages and national stockpile issues, including H.R. 2870, the Essential Medicines Strategic Stockpile Act of 2021. Issues related to COVID-19 vaccine distribution. Issues related to the implementation of H.R. 1319, the American Rescue Plan. Issues related to pharmacy provider status. Issues related to oncology medicines in H.R. 5067, the Preserving Patient Access to Home Infusion Act. Issues related to drug pricing in H.R. 5376, the Build Back Better Act.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LORI DENHAM —
CLAYTON PATRICK HAYES —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Executive Office of the President (EOP); SENATE

Bills named: H.R. 2870 (117th), H.R. 1319 (117th), H.R. 5376 (117th), H.R. 5067 (117th)

Defense DEF

Issues related to drug shortages and stockpile issues at the Department of Defense. Issues related to pharmaceutical provisions in S.1605, the National Defense Authorization Act for Fiscal Year 2022.

LobbyistCovered position, as disclosed
LORI DENHAM —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE

Bills named: S. 1605 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.